By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The National Institute of Diabetes and Digestive and Kidney Diseases will fund $30 million in new grants that will use a wide range of genomics, epigenomics, high-throughput screening, and other approaches for type 1 diabetes (T1D) research, according to a National Institutes of Health funding announcement.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

The Wall Street Journal looks into the cost of new gene therapies.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.